↓ Skip to main content

Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis

Overview of attention for article published in Cochrane database of systematic reviews, June 2020
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis
Published in
Cochrane database of systematic reviews, June 2020
DOI 10.1002/14651858.cd013650
Authors

Takayoshi Kanie, Atsushi Mizuno, Daisuke Yoneoka, Wilson Wai San Tam, Jakub Morze, Andrzej Rynkiewicz, Yiqiao Xin, Olivia Wu, Joey SW Kwong

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 12%
Student > Master 2 12%
Student > Doctoral Student 1 6%
Librarian 1 6%
Researcher 1 6%
Other 0 0%
Unknown 10 59%
Readers by discipline Count As %
Medicine and Dentistry 4 24%
Pharmacology, Toxicology and Pharmaceutical Science 2 12%
Agricultural and Biological Sciences 1 6%
Unknown 10 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2020.
All research outputs
#6,600,501
of 25,462,162 outputs
Outputs from Cochrane database of systematic reviews
#7,973
of 12,090 outputs
Outputs of similar age
#141,800
of 435,293 outputs
Outputs of similar age from Cochrane database of systematic reviews
#101
of 135 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,293 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 135 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.